Safer proteinase treatment of sciatica A biochemical preview of chymopapain inhibitors
- 1 January 1988
- journal article
- review article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 59 (1), 63-65
- https://doi.org/10.3109/17453678809149347
Abstract
As pointed out in the preceding review (Nachemson and Rydevik 1988), the most serious and common complications of chymopapain treatment of patients with sciatica due to disc herniation are cerebral or subarachnoid hemorrhages and allergic manifestations. Recent progress in biochemical and physiologic studies of cysteine proteinases and their inhibitors allows some speculation on how these complications in the future might be alleviated or avoided and on how the efficiency of proteinase treatment of patients with sciatica might be increased.Keywords
This publication has 8 references indexed in Scilit:
- Chemonucleolysis for sciatica A critical reviewActa Orthopaedica, 1988
- The cystatins: a new class of peptidase inhibitorsTrends in Biochemical Sciences, 1987
- Hereditary cystatin C (γ-trace) amyloid angiopathy of the CNS causing cerebral hemorrhageActa Neurologica Scandinavica, 1987
- The Biochemistry of the Action of Chymopapain in Relief of SciaticaSpine, 1986
- Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatinBiochemical Journal, 1986
- Abnormal Metabolism of γ-Trace Alkaline MicroproteinNew England Journal of Medicine, 1984
- In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorptionBiochemical and Biophysical Research Communications, 1984
- ChymopapainPublished by Wolters Kluwer Health ,1965